(614)355-5560
June 16, 2022
Flovent HFA Inhaler Now Has a Generic; Brand Still Preferred for Medicaid Patients

Fluticasone propionate HFA (Flovent® HFA) is an inhaled corticosteroid used first-line for pediatric patients with asthma that require an everyday controller medication. Flovent® HFA has established dosing for all ages and is compatible with a mask and spacer, making it the most prescribed controller inhaler for pediatric patients.

Beginning July 1, 2022, Flovent® HFA will have a preferred brand over generic designation on the Ohio Medicaid unified preferred drug list (UPDL). This is a result of fluticasone propionate generic inhaler launching into the marketplace. This transition may cause your office to receive prior authorizations from pharmacies that process the prescription for the generic medication (which is the default of most pharmacy systems). It is not necessary to submit the prior authorization; instead, communicate with the pharmacy to process the prescription for brand name Flovent® and that should result in a paid claim. This change will be highlighted on Partners For Kids July UPDL updates and additional details will be included in this document to assist pharmacies in processing the medication correctly.

 

Related Articles
Pharmacy Updates
January 19, 2023
Quarterly Update for PFK’s Pediatric-Focused Unified Preferred Drug List
Read More
Pharmacy Updates
January 19, 2023
Prescribing Guidance During Antibiotic Shortages
Review information on alternative dosage forms and antibiotics to help your practice navigate current antibiotic shortages.
Read More
Pharmacy Updates
December 15, 2022
Amphetamine Mixed Salts Shortage
Review Partners For Kids alternative formulary recommendations.
Read More
Pharmacy Updates
December 15, 2022
Flu Season has Arrived
Review Partners For Kids alternative formulary recommendations.
Read More
Pharmacy Updates
December 12, 2022
Mixed Amphetamine Salts (Adderall IR and ER®) Shortage Information
Read More
Pharmacy Updates
December 1, 2022
Amphetamine Mixed Salts (Adderall® and generic formulations) Shortage
Read More